rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

MSA Safety Incorporated

MSA · NYSE

Health CareMedical DevicesAbove a falling average

MSA stood above a rising 150-day average in 20 of the last 52 weekly readings, and has been out of that trend for the last 4 weeks. It is 2.4% above that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Above a falling average
Weeks in an uptrend
out for 4
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$142K
Insider sales, 12 months
$8.4M
Officials’ trades on record
4
Institutions holding
422 (+8)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 20 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$7.6M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

4 disclosed lines: House 1, Senate 0, executive 3; 2 people.

WhoDidAmountTraded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k24 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$15k–$50k22 May 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k18 May 2026filed 1 Jul 2026
Van Taylor House: U.S. House ClerkTX03sold$1k–$15k25 Mar 2019filed 15 Apr 2019

Insiders

Buy orders, 12 months1
Sale orders, 12 months4
Buyers · sellers1 · 2
WhoDidSharesTraded
Nishan J. VartanianDirector, Othersold20,000at $193.997 Aug 2026filed 11 Aug 2026
Jonathan D. BuckChief Accounting Officersold469at $191.004 Aug 2026filed 5 Aug 2026
Julie A. BeckChief Financial Officerbought448at $158.6911 Jun 2026filed 12 Jun 2026
Jonathan D. BuckChief Accounting Officersold1,100at $203.4817 Feb 2026filed 18 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders422+8 on the quarter
New · exited52 · 45
Reported value$5.9B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20263,331,741$581.7M+80,024+2.5%
VANGUARD PORTFOLIO MANAGEMENT LLCreduced · filed 13 Aug 20261,828,682$319.3M-13,581−0.7%
Ruane, Cunniff & Goldfarb L.P.reduced · filed 14 Aug 20261,721,415$300.5M-54,867−3.1%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20261,708,900$298.3M+5,117+0.3%
STATE STREET CORPadded · filed 7 Aug 20261,626,476$283.8M+87,786+5.7%
JPMORGAN CHASE & COnew · filed 12 Aug 2026796,788$137.4M+796,788
DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 2026773,699$135.1M+15,355+2.0%
COOKE & BIELER LPreduced · filed 30 Jul 2026725,229$126.6M-120,259−14.2%
FIDUCIARY MANAGEMENT INCadded · filed 13 Aug 2026713,768$124.6M+34,782+5.1%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026691,769$120.8M-2510.0%
31 Mar 2023 – 30 Jun 2026
220317414Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

William M. Lambert Company insiderDirector · last 14 Sep 20261 · 45
Diane M. Pearse Company insiderDirector · last 10 Sep 20260 · 6
Gregory B. Jordan Company insiderDirector · last 10 Sep 20260 · 0
Luca Savi Company insiderDirector · last 10 Sep 20260 · 0
Sandra L. Phillips Company insiderDirector · last 10 Sep 20260 · 1
Julie A. Beck Company insiderChief Financial Officer · last 31 Aug 20261 · 0
Nishan J. Vartanian Company insiderDirector, Other · last 7 Aug 20260 · 24
Jonathan D. Buck Company insiderChief Accounting Officer · last 4 Aug 20260 · 9
Octavio Marquez Company insiderDirector · last 4 Aug 20260 · 0
Donald J. Trump Executive branchWhite House Office · last 24 Jun 20260 · 3
Steven C. Blanco Sr. Company insiderCEO · last 12 Jun 20260 · 6
Richard W. Roda Company insiderVice President, Secretary, CLO · last 21 May 20260 · 0

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202512.8%
Operating profit marginFY 2025 · to 31 Dec 202519.8%
Free cash flow marginFY 2025 · to 31 Dec 202515.8%
Return on capital employedFY 2025 · to 31 Dec 202516.4%
Cash conversionFY 2025 · to 31 Dec 2025130%
Debt to equityFY 2025 · to 31 Dec 20250.43×
Research spendFY 2025 · to 31 Dec 20253.5%
Revenue growthFY 2025 · to 31 Dec 2025300%
Earnings per share growthFY 2025 · to 31 Dec 202524.9%
Share count trendFY 2025 · to 6 Feb 2026-0.4%
Cash and equivalentsFY 2025 · to 31 Dec 2025$165.1M
Free cash flowFY 2025 · to 31 Dec 2025$295.4M

Analyst forecasts

No analyst forecasts yet.